Connor, Clark & Lunn Investment Management (CC&L)’s ADMA Biologics ADMA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-66,740
| Closed | -$1.32M | – | 1487 |
|
|
2025
Q1 | $1.32M | Sell |
66,740
-97,146
| -59% | -$1.93M | 0.01% | 860 |
|
|
2024
Q4 | $2.81M | Sell |
163,886
-424,988
| -72% | -$7.29M | 0.01% | 636 |
|
|
2024
Q3 | $11.8M | Sell |
588,874
-202,917
| -26% | -$4.06M | 0.06% | 242 |
|
|
2024
Q2 | $8.85M | Buy |
791,791
+466,551
| +143% | +$5.22M | 0.04% | 300 |
|
|
2024
Q1 | $2.15M | Sell |
325,240
-69,668
| -18% | -$460K | 0.01% | 650 |
|
|
2023
Q4 | $1.78M | Sell |
394,908
-162,255
| -29% | -$733K | 0.01% | 699 |
|
|
2023
Q3 | $1.99M | Sell |
557,163
-267,487
| -32% | -$958K | 0.01% | 625 |
|
|
2023
Q2 | $3.04M | Buy |
824,650
+6,466
| +0.8% | +$23.9K | 0.02% | 498 |
|
|
2023
Q1 | $2.71M | Buy |
818,184
+3,348
| +0.4% | +$11.1K | 0.01% | 492 |
|
|
2022
Q4 | $3.16M | Buy |
814,836
+649,198
| +392% | +$2.52M | 0.02% | 445 |
|
|
2022
Q3 | $403K | Buy |
165,638
+134,186
| +427% | +$326K | ﹤0.01% | 863 |
|
|
2022
Q2 | $62K | Buy |
+31,452
| New | +$62K | ﹤0.01% | 1003 |
|